Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The End of B/Yamagata Influenza Transmission — Transitioning from Quadrivalent Vaccines

28 Feb 2024

Abstract excerpt

Since the Yamagata lineage of type B influenza has not circulated since early 2020, experts agree that countries using a quadrivalent influenza vaccine should return to a trivalent one.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Data-Driven Disease Surveillance
Share to Influenza Virus Research Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38416423
DOI: 10.1056/nejmp2314801

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The End of B/Yamagata Influenza Transmission — Transitioning from Quadrivalent VaccinesPMID 38416423Read ↗

Implications of the apparent extinction of B/Yamagata-lineage human influenza virusesSemantic proximity Read ↗

Post-disappearance scenarios: policy implications following the potential disappearance of B/Yamagata lineage influenza virusesSemantic proximity Read ↗

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st centurySemantic proximity Read ↗

Vaccine Mismatches, Viral Circulation, and Clinical Severity Patterns of Influenza B Victoria and Yamagata Infections in Brazil over the Decade 2010–2020: A Statistical and Phylogeny–Trait AnalysesSemantic proximity Read ↗

Quadrivalent Ann Arbor strain live-attenuated influenza vaccineSemantic proximity Read ↗

Influenza A viruses: why focusing on M2e-based universal vaccinesSemantic proximity Read ↗

Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccineSemantic proximity Read ↗

Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of AgeSemantic proximity Read ↗

Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage eliminationSemantic proximity Read ↗

Influenza vaccines: challenges and solutions.Semantic proximity Read ↗

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018Semantic proximity Read ↗

The Coming Era of Quadrivalent Human Influenza VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.